Pennsylvania + Wall



 

Pennsylvania + Wall provides commentary on a broad range of current financial, economic and regulatory reform topics. The views expressed are those of the authors, and do not necessarily reflect the position of SIFMA.

September 27, 2016

'A Stronger Sense of Purpose': Jack Dorsey on Technology and Economic Growth & Empowerment

By Tom Price 

Kicking off  SIFMA's 2016 Annual Meeting, The Capital Markets Conference, Twitter and Square Co-Founder and CEO Jack Dorsey discussed technology as a tool for economic growth and empowerment, both on an individual level and on a broader scale.

Jack DorseyatSIFMA-Annual2016

In discussion with Marty Chavez, Chief Information Officer (CIO) of Goldman Sachs, Dorsey traced the integral roles of entrepreneurship and community. "It took me a long time to think not just about going broad, but to think about going deep." He emphasized the role of entrepreneurship in fostering "a sense of care, a stronger sense of purpose.".... Read more...

September 27, 2016

Rallying for Free Markets and Free Enterprise

By Kenneth E. Bentsen, Jr.

Looking at the future of financial markets, former Treasury Secretary Hank Paulson and former UK Chancellor of the Exchequer, First Secretary of State and and current Member of Parliament George Osborne see the return of politics and political risk to the global economy. In a discussion at SIFMA's 2016 Annual Meeting, The Capital Markets Conference, in Washington DC, the two touched on regulation of financial markets, green finance, and monetary policy, but the overarching theme of the conversation was the effect of politics on the economy.

Rallying for Free Markets and Free Enterprise "You see political risk returning across the world," Osborne added, saying that politicians "vying with each other to see what barriers they can erect to trade is not very encouraging." Osborne noted that while this "return of politics" may be alarming, it is necessary to identify and address "people's concerns that they aren't getting the fruits of the system." That doesn't mean changing monetary policy, he argued, but finding "an ameliorating alternative." It is important to garner "support for real markets" and free enterprise..... Read more...

August 26, 2016

Basel Reforms Require Further Review

By Kenneth E. Bentsen, Jr.

The following commentary was originally published in Bloomberg Brief: Financial Regulation & Risk  on August 26, 2016.

Ken BentsenKenneth E. Bentsen, Jr., President and CEO of SIFMA, and CEO of the Global Financial Markets Association (GFMA), discusses the wide-reaching impact of Basel reforms on markets and the economy following the release of a report by Oliver Wyman, commissioned by the GFMA. GFMA is SIFMA's global affiliate.

"Following the financial crisis, G-20 Leaders agreed to take steps to enhance financial stability, which led to an unprecedented regulatory overhaul driven by the Financial Stability Board and Basel Committee on Banking Supervision. This resulted in significant increases in capital and liquidity and lower leverage, complemented by measures to improve market infrastructures and reduce risks from concentrated exposures and interconnectedness. While the standards developed greatly improved the resilience of the financial system, which has since proved itself in both real and simulated periods of stress, they were developed independently and their impacts were evaluated mainly in isolation. As a result, there has never been a comprehensive analysis of their aggregate impact on the structure and functioning of banks and financial markets, nor on economic costs, growth and job creation."

Continue reading at newsletters.briefs.bloomberg.com.... Read more...

August 01, 2016

Funding Innovation in Biotech: A Conversation with Congress and Industry Analysts

By: Kyle Brandon

It can take 14 years and up to $2 billion to bring a medicine to market. How does the biotech industry fund extraordinary innovations? Venture capital investments and capital markets (i.e. IPOs and secondary offerings).

Biotechnology is an evolving industry that improves lives through the development of treatments and cures for some of today's most pressing medical challenges, while also fueling innovation, economic growth and job creation across America. At a roundtable discussion on Capitol Hill, Members of Congress and industry analysts from RBC Capital Markets and Jefferies discuss the state of the biotech industry today and the role of America's capital markets in funding new innovations..... Read more...

July 27, 2016

A Wall Street Experience: 2016 InvestWrite Winners Visit New York City

A Wall Street Experience: 2016 InvestWrite Winners Visit New York City This June, the SIFMA Foundation hosted two middle-school and two high-school students, their families, and their teachers in the financial capital of the world: New York City. The students earned their tickets by placing first nationally in the fall and spring sessions of SIFMA Foundation’s InvestWrite essay competition. InvestWrite challenges students to think critically, and analyze various investment scenarios and generate long term recommendations. The four winners were selected from more than 20,000 participants. .... Read more...

July 26, 2016

The Cybersecurity Industry Today: A Conversation with Congress and the Financial Services Industry

By: Tom Wagner

At a roundtable discussion on Capitol Hill, Members of Congress gathered with financial industry experts from Goldman Sachs, Morgan Stanley and Wunderlich Securities to discuss the state of the cybersecurity industry today and the role of America's capital markets in funding cybersecurity initiatives..... Read more...

July 15, 2016

Podcast: SIFMA's Economic Advisory Roundtable Revises 2016 GDP Growth Down to 1.8%

Stuart Hoffman, senior vice president and chief economist for The PNC Financial Services Group and Chair of SIFMA's Economic Advisory Roundtable, discusses the Roundtable's U.S. Mid-Year 2016 Economic Outlook. .... Read more...

       1 2 3 4 5  ...        



Join SIFMA

Learn How ›

Subscribe

Sign up for e-mail alerts:

First Name:

Last Name:

Email:


Enter ›

SIFMA Blog Sign-up by RSS feed



Contact

Katrina Cavalli
212.313.1181

 

Liz Pierce  

212.313.1173

 

Carol Danko
202.962.7390


Search Blog




Post a Comment

We encourage you to submit comments, queries and suggestions on our blog entries. Comments must be relevant to the post, and contribute to a substantive and informed dialogue for our fellow blog readers. We will post them below the entry, subject to the following guidelines:

View Guidelines

+
  • Please be thoughtful: Comments must be relevant to the post.
  • Please be brief: Comments are limited to 1500 characters. 
  • Please be prompt: Comments submitted more than one week after the blog entry appears may not be posted. 
  • Please be on-topic and patient: Comments are moderated and will not appear until they have been reviewed to ensure that they are substantive and clearly related to the topic of the post. 

This is a community please treat others with respect.  Specifically, please refrain from comments that are:

  • self-promotional or commercial in nature;
  • investment advice, or mentions of individual stocks;
  • abusive, harassing, or threatening;
  • obscene or vulgar; or
  • as well as comments that constitute a personal attack.  

We reserve the right not to post a comment; no notice will be given regarding whether a submission will or will not be posted.

Please contact us directly if you have any questions or suggestions.
Kate Zickel
Michelle Vandamme
Jeana Zamanski


Market Data